In the peripheral compartment, PD did not significantly modulate myeloid trafficking compared to the levels observed in the stroke-only group (Figure 3(f)), nor were plasma concentrations of IL-1β, IL-17A, and GM-CSF altered (Figure 3(g)). The gene discussed is IL1B; the disease is stroke disorder.